Detalhe da pesquisa
1.
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age.
N Engl J Med
; 388(7): 621-634, 2023 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36791162
2.
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
N Engl J Med
; 386(1): 35-46, 2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34752019
3.
Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds.
J Pediatric Infect Dis Soc
; 12(4): 234-238, 2023 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36929216